{"id":19274,"date":"2023-08-14T17:03:04","date_gmt":"2023-08-14T14:03:04","guid":{"rendered":"https:\/\/stage.www.cobalt.legal\/?p=19274"},"modified":"2023-08-14T17:03:04","modified_gmt":"2023-08-14T14:03:04","slug":"theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai","status":"publish","type":"post","link":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/","title":{"rendered":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?"},"content":{"rendered":"

\u0160i\u0173 met\u0173 prad\u017eioje Theranos steig\u0117ja Elizabeth Holmes buvo pripa\u017einta kalta d\u0117l suk\u010diavimo ir melavimo apie savo kurt\u0105 produkt\u0105. Tai apibendrina vis\u0105 daugiau nei 10 met\u0173 veikusio, spar\u010diai augusio ir daug \u017eadan\u010dio startuolio, kuris pritrauk\u0117 vir\u0161 900 mln. USD investicij\u0173 i\u0161 \u012fvairi\u0173 \u017einom\u0173 investuotoj\u0173, istorij\u0105. Investuotoj\u0173 investicijos prarastos. Startuolio steig\u0117jai, buvusiai Silicio sl\u0117nio \u017evaig\u017edei, gresia iki 20 m. laisv\u0117s at\u0117mimo bausm\u0117. Theranos kurta pasaka, deja, ne su s\u0117kminga pabaiga. Tad \u012f k\u0105 investuotojai, startuoliai ir steig\u0117jai tur\u0117t\u0173 atkreipti d\u0117mes\u012f, kad jie neatsidurt\u0173 pana\u0161iose situacijose?<\/strong><\/p>\n

Startuolio patikrinimas (ang.<\/em> due diligence<\/em>): ar tikrai b\u016btinas? <\/strong><\/p>\n

Theranos id\u0117ja atrod\u0117 itin novatori\u0161ka ir patraukli \u2013 vienu d\u016briu paimtas kraujo la\u0161as leist\u0173 nustatyti \u012fvairias ligas. Jei b\u016bt\u0173 \u012fgyvendinta, ji b\u016bt\u0173 suk\u0117lusi revoliucij\u0105 sveikatos prie\u017ei\u016bros pramon\u0117je. Tad nenuostabu, kad \u0161i id\u0117ja, pristatoma jaunos ir \u012ftaigios moters, patrauk\u0117 daugelio investuotoj\u0173 d\u0117mes\u012f.<\/p>\n

Deja, didel\u0117 dalis Theranos investuotoj\u0173 neatliko i\u0161samaus startuolio ir jo komandos patikrinimo. Pirmieji rimtesni investuotojai buvo pritraukti ry\u0161i\u0173 pagalba pasitikint steig\u0117jos pie\u0161iama vizija, deklaratyviais teiginiais. Sekantys investuotojai da\u017enu atveju prisijungdavo pasitik\u0117dami jau esamais investuotojais (t.y. jei jau s\u0117kmingas investuotojas investavo, tai yra pakankamas pagrindas investuoti ir kitam investuotojui). Theranos teikdavo aptaki\u0105 informacij\u0105, kartais netgi demonstruodavo produkt\u0105 ir jo veikimo rezultatus (tiesa, rezultatams gauti buvo pasitelkiama konkurent\u0173 \u012franga), ta\u010diau visa \u0161i informacija ir galimos rizikos nebuvo i\u0161samiai vertinami. Ai\u0161ku, dabar lengva apie tai kalb\u0117ti, bet daugelis nepriklausom\u0173 medicinos ekspert\u0173 pabr\u0117\u017eia, kad Theranos produktas tur\u0117jo daug esmini\u0173 tr\u016bkum\u0173, kurie gal\u0117jo b\u016bti atskleisti nuo pat prad\u017ei\u0173 atlikus nesud\u0117ting\u0105 vertinim\u0105.<\/p>\n

Taigi, investuotojai turi nepamir\u0161ti, kad teisinis, finansinis, mokestinis, o sud\u0117tingesniais atvejais ir labiau specializuotas (technologinis ar pan.) patikrinimas vis tik yra reikalingas. Nepaisant to, kad tai reikalauja laiko ir pinig\u0173, investuotojai turi skirti tam pakankamai d\u0117mesio, aklai nepasitik\u0117ti kitais startuolio investuotojais ar steig\u0117j\u0173 pa\u017eadais. Investuotojai turi pakankamai \u012fsigilinti \u012f startuolio id\u0117j\u0105, veikl\u0105, turi suprasti verslo model\u012f ir pat\u012f produkt\u0105. Kitaip atpa\u017einti klaidas ir galim\u0105 mel\u0105 bus sud\u0117tinga arba tai ilgai u\u017etruks (kaip tai \u012fvyko Theranos atveju).<\/p>\n

Atvirumo svarba: investuotojai gali pad\u0117ti i\u0161spr\u0119sti steig\u0117j\u0173 sunkumus<\/strong><\/p>\n

Kaip jau min\u0117ta, Theranos atveju id\u0117ja buvo i\u0161ties patraukli. Ta\u010diau nes\u0117kminga. Galima b\u016bt\u0173 sakyti, kad Theranos buvo vienas i\u0161 t\u0173 nes\u0117kming\u0173 startuoli\u0173, kuriems tiesiog nepavyko (juk taip da\u017enai \u012fvyksta, tik nedaugeliui pavyksta \u201ei\u0161\u0161auti\u201c). Visgi teismas patvirtinto, kad Theranos istorija, kuri truko daugiau nei 10 met\u0173, buvo gr\u012fsta melu ir apgaudin\u0117jimu. Theranos teiginiai apie kuriam\u0105 produkt\u0105, apie veiklos ir finansinius rodiklius buvo arba perd\u0117ti, arba klaidingi.<\/p>\n

Pasimokant i\u0161 visos Theranos istorijos, steig\u0117jams patartina neb\u016bti pernelyg entuziastingiems pie\u0161iant investuotojams ateit\u012f. Optimizmas ir tik\u0117jimas savo id\u0117ja yra b\u016btinas, bet nereik\u0117t\u0173 persistengti su pa\u017eadais. Steig\u0117jai tur\u0117t\u0173 b\u016bti s\u0105\u017einingi ir atviri su investuotojais ir, ai\u0161ku, pa\u010diais savimi. Jie netur\u0117t\u0173 bijoti kalb\u0117t apie nes\u0117kmes bei kartu ie\u0161koti sprendim\u0173. Juk investuotojai turi patirties, yra susid\u016br\u0119 su \u012fvairiomis situacijomis ir savo \u017einiomis gali prisid\u0117ti prie startuoliams kylan\u010di\u0173 problem\u0173 sprendimo. Kita vertus, investuotojai tur\u0117t\u0173 i\u0161likti budr\u016bs, atid\u017eiai vertinti steig\u0117j\u0173 pa\u017eadus ir remtis ne vien j\u0173 teiginiais, bet reikalauti ir toki\u0173 teigini\u0173 pagrindimo.<\/p>\n

Tinkamos komandos ir aplinkos vaidmuo<\/strong><\/p>\n

Theranos steig\u0117ja savo startuol\u012f \u012fk\u016br\u0117 19 m., netur\u0117dama jokios verslo ar gamybos patirties. Ji taip pat netur\u0117jo ir medicininio i\u0161silavinimo. Tam, kad b\u016bt\u0173 lengviau pritraukti investuotojus, \u012f savo vadov\u0173 komand\u0105 ji pritrauk\u0117 labiau visuomenei \u017einomus asmenis (pvz., politikus), bet ne tuos, kurie tur\u0117jo patirties ir kompetencij\u0173, reikaling\u0173 s\u0117kmingam Theranos id\u0117jos \u012fgyvendinimui.<\/p>\n

Theranos istorija pamoko, kad steig\u0117jai tur\u0117t\u0173 ie\u0161koti vis\u0173 pirma savo srities specialist\u0173, dar geriau, jei jie \u017eino ir i\u0161mano daugiau u\u017e pa\u010dius steig\u0117jus, meta i\u0161\u0161\u016bkius, kelia klausimus ir ie\u0161ko sprendim\u0173. \u017dinomi vardai lengviau pritraukia d\u0117mes\u012f, bet netur\u0117dami specifini\u0173 \u017eini\u0173 jie nei\u0161vystys startuolio id\u0117jos, ypa\u010d jei ji yra sud\u0117tinga ir reikalaujanti specialios kompetencijos. Kita vertus, investuotojai kaskart tur\u0117t\u0173 \u012fvertinti komandos\u00a0 tinkamum\u0105 \u2013 ar jie turi pakankamai \u017eini\u0173, ar fakti\u0161kai i\u0161mano t\u0105 srit\u012f ir, jei reikia, pad\u0117ti startuoliams su tinkamu komandos sutelkimu.<\/p>\n

Theranos komanda taip pat pasi\u017eym\u0117jo ir gan toksi\u0161ka, nepasitik\u0117jimu ir u\u017edar\u0173 dur\u0173 politika gr\u012fsta aplinka. Skyriai buvo atskirti, bendravimas tarp j\u0173 prakti\u0161kai neegzistavo. Tik labai nedidel\u0117 darbuotoj\u0173 dalis tur\u0117jo informacijos, kuri leido matyti bent kiek ai\u0161kesn\u0119 startuolio pad\u0117t\u012f. Darbuotojai, keliantys klausimus ar abejones, buvo atleid\u017eiami, jiems b\u016bdavo grasinama nebandyti vie\u0161ai atskleisti apie Theranos problemas. Tokia slaptumu ir bauginimu gr\u012fsta valdysena pad\u0117jo Theranos steig\u0117jai ilgus metus kurti melu gr\u012fst\u0105 istorij\u0105 apie jos kuriam\u0105 revoliucij\u0105 tur\u0117jus\u012f sukelti produkt\u0105.<\/p>\n

Tad sekanti pamoka steig\u0117jams yra kurti bendradarbiavimu ir skaidrumu gr\u012fst\u0105 darbo kult\u016br\u0105. Tik taip visos komandos pad\u0117s verslui jud\u0117ti ta pa\u010dia kryptimi. Tuo pa\u010diu investuotojai tur\u0117t\u0173 \u012fvertinti, startuolio organizacij\u0105, kaip ji veikia, kas ir kam atsakingas, kaip priimami sprendimai, ir t.t.<\/p>\n

Atlikite nam\u0173 darbus \u2013 nepasiduosite \u012fdomios vizijos impulsui<\/strong><\/p>\n

Apibendrinant, steig\u0117jams ir investuotojams lengva pasiduoti \u012fdomios vizijos impulsui. Ta\u010diau investavimas turi savo \u012fprastinius etapus (planavimas, patikrinimas ir t.t.). \u0160ie procesai buvo primir\u0161ti Theranos istorijos atveju. Nors Theranos nes\u0117km\u0119 u\u017eprogramavo pati steig\u0117ja su nerealiais ir perd\u0117tais pa\u017eadais, investuotojai, nesilaikydami \u012fprastini\u0173 taisykli\u0173, patys prisid\u0117jo prie savo finansin\u0117s nes\u0117km\u0117s. Kad netapt\u0173 toki\u0173 pasak\u0173 kaip Theranos herojais, investuotojai tur\u0117t\u0173 nepamir\u0161ti atlikti savo nam\u0173 darb\u0173: surinkti informacij\u0105 apie startuol\u012f, jo steig\u0117jus, pasitelkti ekspertus \u0161iai informacijai i\u0161analizuoti, atsakingai \u012fvertinti \u012f\u017evelgiamas problemas (pvz., kompetencij\u0173 tr\u016bkumas, geros valdysenos spragos, aplaidi apskaita ar pan.), jei toliau einama \u012f sandor\u012f \u2013 nustatyti, kaip tos problemos bus sprend\u017eiamos (t\u0105 galima aptarti ir pa\u010dioje investavimo sutartyje, o investicijos i\u0161mok\u0117jim\u0105 sieti su problem\u0173 i\u0161sprendimu), pasirengti tinkamus investavimo dokumentus (su steig\u0117j\u0173 patvirtinimais ir garantijomis, su j\u0173 pareiga teikti informacij\u0105 investuotojams, gauti investuotoj\u0173 pritarim\u0105 svarbiausiems klausimams ir pan.).<\/p>\n

Investuotojai taip pat tur\u0117ti i\u0161likti aktyv\u016bs po investavimo raundo (dalyvauti pos\u0117d\u017eiuose, dom\u0117tis, kelti klausimus, dalintis savo patirtimi). Tuo tarpu startuoliai ir steig\u0117jai tur\u0117ti b\u016bti atviri su investuotojais, pasitik\u0117ti ir bendradarbiauti su jais. Jie tur\u0117t\u0173 pateikti investuotojams vis\u0105 j\u0173 pra\u0161om\u0105 informacij\u0105, atid\u017eiai susipa\u017einti su investavimo dokumentais (su savo pareigomis, pateikiamas patvirtinimais apie \u012fmon\u0119, jos veikl\u0105, finansus ir pan.), atid\u017eiai dalinti pa\u017eadus, nebijoti pra\u0161yti patarim\u0173 ir mokytis i\u0161 investuotoj\u0173, burti kompetenting\u0105 ir darni\u0105 komand\u0105.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u0160i\u0173 met\u0173 prad\u017eioje Theranos steig\u0117ja Elizabeth Holmes buvo pripa\u017einta kalta d\u0117l suk\u010diavimo ir melavimo apie savo kurt\u0105 produkt\u0105. Tai apibendrina vis\u0105 daugiau nei 10 met\u0173 veikusio, spar\u010diai augusio ir daug \u017eadan\u010dio startuolio, kuris pritrauk\u0117 vir\u0161 900 mln. USD investicij\u0173 i\u0161..<\/p>\n","protected":false},"author":6,"featured_media":9864,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[29],"country":[92],"class_list":["post-19274","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-lt","country-lithuania-lt"],"acf":[],"yoast_head":"\nTheranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai? | COBALT<\/title>\n<meta name=\"description\" content=\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai? | COBALT\" \/>\n<meta property=\"og:description\" content=\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/\" \/>\n<meta property=\"og:site_name\" content=\"COBALT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CobaltLegal\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-14T14:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/Eva-Suduiko2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2044\" \/>\n\t<meta property=\"og:image:height\" content=\"1788\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ilze Augstkalne\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ilze Augstkalne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minut\u0117s\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/\"},\"author\":{\"name\":\"Ilze Augstkalne\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/a96c052a2eba55b2f6b995c69436c3aa\"},\"headline\":\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?\",\"datePublished\":\"2023-08-14T14:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/\"},\"wordCount\":1137,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Eva-Suduiko2.jpg\",\"articleSection\":[\"Uncategorized @lt\"],\"inLanguage\":\"lt-LT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/\",\"name\":\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai? | COBALT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Eva-Suduiko2.jpg\",\"datePublished\":\"2023-08-14T14:03:04+00:00\",\"description\":\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?. News. Naujienos. Jaunumi. Uudised.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Eva-Suduiko2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Eva-Suduiko2.jpg\",\"width\":2044,\"height\":1788},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"name\":\"COBALT\",\"description\":\"Top-tier law services in Estonia, Latvia and Lithuania\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\",\"name\":\"COBALT\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"width\":400,\"height\":116,\"caption\":\"COBALT\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CobaltLegal\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/a96c052a2eba55b2f6b995c69436c3aa\",\"name\":\"Ilze Augstkalne\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/author\\\/ilze\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai? | COBALT","description":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?. News. Naujienos. Jaunumi. Uudised.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/","og_locale":"lt_LT","og_type":"article","og_title":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai? | COBALT","og_description":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?. News. Naujienos. Jaunumi. Uudised.","og_url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/","og_site_name":"COBALT","article_publisher":"https:\/\/www.facebook.com\/CobaltLegal\/","article_published_time":"2023-08-14T14:03:04+00:00","og_image":[{"width":2044,"height":1788,"url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/Eva-Suduiko2.jpg","type":"image\/jpeg"}],"author":"Ilze Augstkalne","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ilze Augstkalne","Est. reading time":"6 minut\u0117s"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#article","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/"},"author":{"name":"Ilze Augstkalne","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/a96c052a2eba55b2f6b995c69436c3aa"},"headline":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?","datePublished":"2023-08-14T14:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/"},"wordCount":1137,"publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/Eva-Suduiko2.jpg","articleSection":["Uncategorized @lt"],"inLanguage":"lt-LT"},{"@type":"WebPage","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/","url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/","name":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai? | COBALT","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#primaryimage"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/Eva-Suduiko2.jpg","datePublished":"2023-08-14T14:03:04+00:00","description":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?. News. Naujienos. Jaunumi. Uudised.","breadcrumb":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#primaryimage","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/Eva-Suduiko2.jpg","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/Eva-Suduiko2.jpg","width":2044,"height":1788},{"@type":"BreadcrumbList","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/theranos-pasakos-pabaiga-ko-turetu-pasimokyti-investuotojai-startuoliai-ir-steigejai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cobalt.legal\/lt\/"},{"@type":"ListItem","position":2,"name":"Theranos pasakos pabaiga \u2013 ko tur\u0117t\u0173 pasimokyti investuotojai, startuoliai ir steig\u0117jai?"}]},{"@type":"WebSite","@id":"https:\/\/www.cobalt.legal\/lt\/#website","url":"https:\/\/www.cobalt.legal\/lt\/","name":"COBALT","description":"Top-tier law services in Estonia, Latvia and Lithuania","publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cobalt.legal\/lt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/www.cobalt.legal\/lt\/#organization","name":"COBALT","url":"https:\/\/www.cobalt.legal\/lt\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","width":400,"height":116,"caption":"COBALT"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CobaltLegal\/"]},{"@type":"Person","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/a96c052a2eba55b2f6b995c69436c3aa","name":"Ilze Augstkalne","url":"https:\/\/www.cobalt.legal\/lt\/author\/ilze\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/19274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/comments?post=19274"}],"version-history":[{"count":1,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/19274\/revisions"}],"predecessor-version":[{"id":19275,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/19274\/revisions\/19275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media\/9864"}],"wp:attachment":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media?parent=19274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/categories?post=19274"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/country?post=19274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}